Long-term survival in community-acquired pneumonia caused by other bacteria than pneumococci is impaired more than in pneumococcal pneumonia: Effect of underlying disease?

Clinical Infectious Diseases

Volumn 57, Issue 9, 2013, Pages 1370-1371

  Bruns, Anke H W ^a   Oosterheert, Jan Jelrik ^a   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; LETTER; LONG TERM SURVIVAL; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVOR;

FEMALE; HUMANS; MALE; PNEUMONIA, PNEUMOCOCCAL;

EID: 84886878116     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit507     Document Type: Letter

References (6)

1. Sandvall B, Rueda AM, Musher DM. Longterm survival following pneumococcal pneumonia. Clin Infect Dis 2013; 56:1145-6.
2. Bruns AH, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered fromcommunity-acquired pneumonia compared with the general Dutch population. Clin Microbiol Infect 2011; 17: 763-8.
3. Bordon J, Wiemken T, Peyrani P, et al. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Chest 2010; 138:279-83.
4. Koivula I, Sten M, Makela PH. Prognosis after community-acquired pneumonia in the elderly: A population-based 12-year follow-up study. Arch Intern Med 1999; 159:1550-5.
5. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis 2003; 37:1617-24.
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50.